Jubilant Ingrevia Ltd (JUBLINGREA) — shareholding pattern, promoter holding, financials and share price

About Jubilant Ingrevia Ltd (JUBLINGREA)

Jubilant Ingrevia Ltd operates in the Specialty Chemicals industry, within the Chemicals sector. It trades on the NSE as JUBLINGREA and on the BSE under scrip code 543271. Its ISIN is INE0BY001018.

Jubilant Ingrevia, a global integrated Life Science products and Innovative Solutions provider serving, Pharmaceutical, Nutrition, Agrochemical, Consumer and Industrial customers with our customised products and solutions that are innovative, cost-effective and conforming to excellent quality standards. Jubilant Ingrevia’s portfolio also extends to custom research and manufacturing for pharmaceutical and agrochemical customers on an exclusive basis. [1]

Jubilant Ingrevia is a global player in Specialty Chemicals, CDMO, Nutrition & Health Solutions serving diverse industries. Its diversified product portfolio includes pyridine derivatives, fine chemicals, pharma, and agro intermediates.

The company is prioritizing expansion, evidenced by new plant constructions aimed at boosting production in agrochemical and specialty chemicals sectors. This will support increased demand and strategic growth expectations.

Listed peers in Specialty Chemicals: Anupam Rasayan India Ltd, Privi Speciality Chemicals Ltd, Vinati Organics Ltd, Alkyl Amines Chemicals Ltd, Clean Science & Technology Ltd, Balaji Amines Ltd.

Valuation & Returns

10 Jul 2026

At ₹722.75 a share on 10 Jul 2026, Jubilant Ingrevia Ltd (JUBLINGREA) was valued at a price-to-earnings ratio of 41.42x against an industry P/E of 45.11x and a price-to-book of 3.93x on a book value of ₹183.77 per share as of Mar 2025. Solomo computes return on equity of 9.49% and return on capital employed of 11.35% from filed results. Earnings ratios use consolidated results for the twelve months Jun 2025 to Mar 2026.

P/E
41.42x
Industry P/E
45.11x
P/B
3.93x
EPS (TTM)
₹17.45
Book value / share
₹183.77
ROE
9.49%
ROCE
11.35%
ROA
5.52%
Debt / equity
0.26x
Dividend yield
0.69%
EBITDA margin
13.68%
52-week range
₹535.3 – ₹851.85

Ratios are computed from filed results and the last recorded price. Not investment advice.

Financial Performance

Mar 2026

In the year ended Mar 2026, Jubilant Ingrevia Ltd (JUBLINGREA) reported revenue of ₹4,388 crore, net profit of ₹278 crore and earnings per share of ₹17.45. That compares with revenue of ₹4,178 crore and net profit of ₹251 crore in Mar 2025. Figures are consolidated, as filed with the exchanges.

In the quarter ended Mar 2026, revenue was ₹1,179 crore and net profit ₹86 crore (consolidated).

Consolidated annual results for Jubilant Ingrevia Ltd (JUBLINGREA), Mar 2022 to Mar 2026. Revenue and net profit in ₹ crore; EPS in ₹ per share.
MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue (₹ cr)4,9494,7734,1364,1784,388
Net profit (₹ cr)477308183251278
EPS (₹)29.9319.3111.4815.7717.45
Compound annual growth for Jubilant Ingrevia Ltd (JUBLINGREA). Stock price CAGR is price return and excludes dividends.
Measure5Y3Y1Y
Sales growth--6.75%1.01%
Profit growth--16.49%37.34%
Stock price CAGR6%23%-8%

Ownership Summary

Jun 2026

As of Jun 2026, promoters hold 45.22% of Jubilant Ingrevia Ltd (JUBLINGREA) (unchanged from the previous quarter), foreign institutional investors (FII) hold 6.49% and domestic institutional investors (DII) hold 24.98%. Promoters have pledged 9.3% of their holding. Market capitalisation was ₹11,512 crore on 10 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Mar 2021.

Largest disclosed public shareholders in Jun 2026: DSP SMALL CAP FUND 8.08%, KOTAK SMALL CAP FUND 3.07%, BANDHAN SMALL CAP FUND 2.48%, HDFC MUTUAL FUND - HDFC MANUFACTURING FUND 2.11%, FRANKLIN INDIA SMALL CAP FUND 1.82%, AXIS MUTUAL FUND TRUSTEE LIMITED A/C AXIS MUTUAL FUND A/C AXIS SMALL CAP FUND 1.81%. Only stakes above the 1% disclosure threshold are named in filings.

QuarterPromoterPledgedFIIDIIPublic
Jun 202645.22%9.3%6.49%24.98%53.79%
Mar 202645.22%7.6%6.49%24.76%53.79%
Dec 202545.22%7.1%6.15%24%53.98%
Sep 202545.22%7.1%5.96%23.04%53.95%
Jun 202545.22%2.2%6.96%21.8%54.06%
Mar 202551.47%2.7%7.12%15.92%47.8%
Dec 202451.47%2.7%6.89%15.99%47.79%
Sep 202451.47%2.7%7.22%15.47%47.76%